Strides Pharma Science Limited (STAR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Strides Pharma Science Limited (STAR) has a cash flow conversion efficiency ratio of 0.140x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.91 Billion ≈ $42.34 Million USD) by net assets (Rs28.03 Billion ≈ $303.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Strides Pharma Science Limited defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Strides Pharma Science Limited - Cash Flow Conversion Efficiency Trend (2005–2026)
This chart illustrates how Strides Pharma Science Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Strides Pharma Science Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Strides Pharma Science Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Oriental Holdings Bhd
KLSE:4006
|
0.060x |
|
Chimera Investment Corporation
NYSE:CIM
|
-0.059x |
|
Whirlpool of India Limited
NSE:WHIRLPOOL
|
0.143x |
|
Lontium Semiconductor Corp. A
SHG:688486
|
N/A |
|
Guangzhou KDT Machinery Co Ltd
SHE:002833
|
0.078x |
|
Shenzhen Farben Information Technology Co.Ltd.
SHE:300925
|
N/A |
|
Hagerty Inc
NYSE:HGTY
|
0.021x |
|
Jingjin Environmental Protection Co Ltd
SHG:603279
|
0.050x |
Annual Cash Flow Conversion Efficiency for Strides Pharma Science Limited (2005–2026)
The table below shows the annual cash flow conversion efficiency of Strides Pharma Science Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see market cap of Strides Pharma Science Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs31.49 Billion ≈ $340.59 Million |
Rs5.39 Billion ≈ $58.31 Million |
0.171x | -35.30% |
| 2025-03-31 | Rs25.86 Billion ≈ $279.72 Million |
Rs6.84 Billion ≈ $74.01 Million |
0.265x | -21.81% |
| 2024-03-31 | Rs20.72 Billion ≈ $224.05 Million |
Rs7.01 Billion ≈ $75.82 Million |
0.338x | +1555.68% |
| 2023-03-31 | Rs21.73 Billion ≈ $234.99 Million |
Rs444.11 Million ≈ $4.80 Million |
0.020x | +118.89% |
| 2022-03-31 | Rs23.83 Billion ≈ $257.75 Million |
Rs-2.58 Billion ≈ $-27.88 Million |
-0.108x | -163.23% |
| 2021-03-31 | Rs28.14 Billion ≈ $304.32 Million |
Rs4.81 Billion ≈ $52.07 Million |
0.171x | +116.77% |
| 2020-03-31 | Rs25.95 Billion ≈ $280.60 Million |
Rs2.05 Billion ≈ $22.15 Million |
0.079x | +268.20% |
| 2019-03-31 | Rs28.02 Billion ≈ $302.99 Million |
Rs600.55 Million ≈ $6.49 Million |
0.021x | -70.10% |
| 2018-03-31 | Rs26.09 Billion ≈ $282.18 Million |
Rs1.87 Billion ≈ $20.23 Million |
0.072x | -28.48% |
| 2017-03-31 | Rs28.74 Billion ≈ $310.86 Million |
Rs2.88 Billion ≈ $31.16 Million |
0.100x | +306.53% |
| 2016-03-31 | Rs29.06 Billion ≈ $314.27 Million |
Rs716.57 Million ≈ $7.75 Million |
0.025x | -65.60% |
| 2015-03-31 | Rs11.64 Billion ≈ $125.84 Million |
Rs834.00 Million ≈ $9.02 Million |
0.072x | +135.70% |
| 2014-03-31 | Rs10.82 Billion ≈ $117.07 Million |
Rs-2.17 Billion ≈ $-23.51 Million |
-0.201x | -413.53% |
| 2013-03-31 | Rs20.98 Billion ≈ $226.90 Million |
Rs1.34 Billion ≈ $14.53 Million |
0.064x | -80.13% |
| 2012-03-31 | Rs14.18 Billion ≈ $153.34 Million |
Rs4.57 Billion ≈ $49.43 Million |
0.322x | +54.77% |
| 2011-03-31 | Rs15.55 Billion ≈ $168.20 Million |
Rs3.24 Billion ≈ $35.03 Million |
0.208x | +255.34% |
| 2010-03-31 | Rs10.90 Billion ≈ $117.83 Million |
Rs638.65 Million ≈ $6.91 Million |
0.059x | -70.36% |
| 2009-03-31 | Rs5.96 Billion ≈ $64.42 Million |
Rs1.18 Billion ≈ $12.74 Million |
0.198x | -41.18% |
| 2008-03-31 | Rs2.94 Billion ≈ $31.74 Million |
Rs987.01 Million ≈ $10.67 Million |
0.336x | +34.31% |
| 2007-03-31 | Rs4.31 Billion ≈ $46.59 Million |
Rs1.08 Billion ≈ $11.66 Million |
0.250x | +9.80% |
| 2006-03-31 | Rs3.47 Billion ≈ $37.48 Million |
Rs790.26 Million ≈ $8.55 Million |
0.228x | -33.74% |
| 2005-03-31 | Rs2.18 Billion ≈ $23.54 Million |
Rs749.22 Million ≈ $8.10 Million |
0.344x | -- |
About Strides Pharma Science Limited
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products f… Read more